This document discusses antisense oligonucleotides, which are short DNA or RNA strands that bind to messenger RNA to inhibit gene expression. It describes the mechanism of action, different generations of oligonucleotides including modifications to improve stability and binding, and applications for disease treatment. First generation oligonucleotides used phosphorothioate modifications and activated RNase H cleavage of mRNA. Second generation used 2' modifications like methyl and prevented RNase H cleavage. Newer generations like PNA, LNA, and CeNA have increased binding and stability. Antisense oligonucleotides have been approved to treat conditions like CMV retinitis and familial hypercholesterolemia.
Antisense oligonucleotides
Antisense therapy is a form of treatment that uses antisense oligonucleotides to target messenger RNA.
(AS ONs) are synthetic DNA oligomers that hybridize to a target RNA in a sequence-specific manner. They have successfully been employed to inhibit gene expression, modulate splicing of a precursor messenger RNA, or inactivate microRNAs.
Antisense oligonucleotides
Antisense therapy is a form of treatment that uses antisense oligonucleotides to target messenger RNA.
(AS ONs) are synthetic DNA oligomers that hybridize to a target RNA in a sequence-specific manner. They have successfully been employed to inhibit gene expression, modulate splicing of a precursor messenger RNA, or inactivate microRNAs.
This slideshare conatins detailed overview of immunotheraphy,humanisation of antibodies and its clinical application
this is the topic from cellular and molecular pharmacology of m pharmacy first year
immunotheraphy is further classified to its various types which has been discussed individually
its also conatins various immunotheraphy drugs which has other clinical advantages
CONCEPT OF PHARMACOPHORE
PHARMACOPHORE MAPPING
IDENTIFICATION OF PHARMACOPHORE FEATURE
CONFORMATIONAL SEARCH
INSILICO DRUG DESIGN
VIRTUAL SCREENING
PHARMACOPHORE BASED SCREENING
First introduced by Paul Heritich in 1990
A pharmacophore is an abstract description of molecular features which are necessary for molecular recognition of a ligand by a biological macromolecule.
It is the key features responsible for an activity (eg. Substrates, inhibitors)
A pharmacophore is a representation of generalized molecular features including;
3D (hydrophobic group, chaeged /ionisable group, hydrogen bond donar/ acceptor)
2D (substructure)
1D (physical & biological)
Pharmacophore Mapping is the definition and placement of pharmacophoric features and the alignment techniques used to overlay 3D.
Two somewhat distinct usages:
That substructure of a molecule that is responsible for its pharmacological activity (c.f. chromophore)
A set of geometrical constraints between specific functional groups that enable the molecule to have biological activity
The process of deriving pharmacophore is known as pharmacophore mapping.
Role of Target Identification and Target Validation in Drug Discovery ProcessPallavi Duggal
Target identification and Validation tells about the how target is neccesary for new drug discovery and its development to reach into market for rare diseases.
ZNF or Zinc Finger proteins
A zinc finger is a small protein structural motif that is characterized by the coordination of one or more zinc ions (Zn2+) in order to stabilize the fold.
The basic aspects of drug discovery starts from target discovery and validation further going to lead identification and optimization. In this particular slide discussion is regarding the target discovery and the tools that have been utilized in this process.
Target Validation
Introduction,Drug discovery, Target identification and validation, Target validation and techniques
By
Ms. B. Mary Vishali
Department of Pharmacology
This slideshare conatins detailed overview of immunotheraphy,humanisation of antibodies and its clinical application
this is the topic from cellular and molecular pharmacology of m pharmacy first year
immunotheraphy is further classified to its various types which has been discussed individually
its also conatins various immunotheraphy drugs which has other clinical advantages
CONCEPT OF PHARMACOPHORE
PHARMACOPHORE MAPPING
IDENTIFICATION OF PHARMACOPHORE FEATURE
CONFORMATIONAL SEARCH
INSILICO DRUG DESIGN
VIRTUAL SCREENING
PHARMACOPHORE BASED SCREENING
First introduced by Paul Heritich in 1990
A pharmacophore is an abstract description of molecular features which are necessary for molecular recognition of a ligand by a biological macromolecule.
It is the key features responsible for an activity (eg. Substrates, inhibitors)
A pharmacophore is a representation of generalized molecular features including;
3D (hydrophobic group, chaeged /ionisable group, hydrogen bond donar/ acceptor)
2D (substructure)
1D (physical & biological)
Pharmacophore Mapping is the definition and placement of pharmacophoric features and the alignment techniques used to overlay 3D.
Two somewhat distinct usages:
That substructure of a molecule that is responsible for its pharmacological activity (c.f. chromophore)
A set of geometrical constraints between specific functional groups that enable the molecule to have biological activity
The process of deriving pharmacophore is known as pharmacophore mapping.
Role of Target Identification and Target Validation in Drug Discovery ProcessPallavi Duggal
Target identification and Validation tells about the how target is neccesary for new drug discovery and its development to reach into market for rare diseases.
ZNF or Zinc Finger proteins
A zinc finger is a small protein structural motif that is characterized by the coordination of one or more zinc ions (Zn2+) in order to stabilize the fold.
The basic aspects of drug discovery starts from target discovery and validation further going to lead identification and optimization. In this particular slide discussion is regarding the target discovery and the tools that have been utilized in this process.
Target Validation
Introduction,Drug discovery, Target identification and validation, Target validation and techniques
By
Ms. B. Mary Vishali
Department of Pharmacology
antisense is a part of medicinal chemistry which helps to the new concept of drugs design and their properties along with their uses and working of it along with the characteristics of different types of antisense molecules
Honest Reviews of Tim Han LMA Course Program.pptxtimhan337
Personal development courses are widely available today, with each one promising life-changing outcomes. Tim Han’s Life Mastery Achievers (LMA) Course has drawn a lot of interest. In addition to offering my frank assessment of Success Insider’s LMA Course, this piece examines the course’s effects via a variety of Tim Han LMA course reviews and Success Insider comments.
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
The Roman Empire A Historical Colossus.pdfkaushalkr1407
The Roman Empire, a vast and enduring power, stands as one of history's most remarkable civilizations, leaving an indelible imprint on the world. It emerged from the Roman Republic, transitioning into an imperial powerhouse under the leadership of Augustus Caesar in 27 BCE. This transformation marked the beginning of an era defined by unprecedented territorial expansion, architectural marvels, and profound cultural influence.
The empire's roots lie in the city of Rome, founded, according to legend, by Romulus in 753 BCE. Over centuries, Rome evolved from a small settlement to a formidable republic, characterized by a complex political system with elected officials and checks on power. However, internal strife, class conflicts, and military ambitions paved the way for the end of the Republic. Julius Caesar’s dictatorship and subsequent assassination in 44 BCE created a power vacuum, leading to a civil war. Octavian, later Augustus, emerged victorious, heralding the Roman Empire’s birth.
Under Augustus, the empire experienced the Pax Romana, a 200-year period of relative peace and stability. Augustus reformed the military, established efficient administrative systems, and initiated grand construction projects. The empire's borders expanded, encompassing territories from Britain to Egypt and from Spain to the Euphrates. Roman legions, renowned for their discipline and engineering prowess, secured and maintained these vast territories, building roads, fortifications, and cities that facilitated control and integration.
The Roman Empire’s society was hierarchical, with a rigid class system. At the top were the patricians, wealthy elites who held significant political power. Below them were the plebeians, free citizens with limited political influence, and the vast numbers of slaves who formed the backbone of the economy. The family unit was central, governed by the paterfamilias, the male head who held absolute authority.
Culturally, the Romans were eclectic, absorbing and adapting elements from the civilizations they encountered, particularly the Greeks. Roman art, literature, and philosophy reflected this synthesis, creating a rich cultural tapestry. Latin, the Roman language, became the lingua franca of the Western world, influencing numerous modern languages.
Roman architecture and engineering achievements were monumental. They perfected the arch, vault, and dome, constructing enduring structures like the Colosseum, Pantheon, and aqueducts. These engineering marvels not only showcased Roman ingenuity but also served practical purposes, from public entertainment to water supply.
Instructions for Submissions thorugh G- Classroom.pptxJheel Barad
This presentation provides a briefing on how to upload submissions and documents in Google Classroom. It was prepared as part of an orientation for new Sainik School in-service teacher trainees. As a training officer, my goal is to ensure that you are comfortable and proficient with this essential tool for managing assignments and fostering student engagement.
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdfTechSoup
In this webinar you will learn how your organization can access TechSoup's wide variety of product discount and donation programs. From hardware to software, we'll give you a tour of the tools available to help your nonprofit with productivity, collaboration, financial management, donor tracking, security, and more.
Operation “Blue Star” is the only event in the history of Independent India where the state went into war with its own people. Even after about 40 years it is not clear if it was culmination of states anger over people of the region, a political game of power or start of dictatorial chapter in the democratic setup.
The people of Punjab felt alienated from main stream due to denial of their just demands during a long democratic struggle since independence. As it happen all over the word, it led to militant struggle with great loss of lives of military, police and civilian personnel. Killing of Indira Gandhi and massacre of innocent Sikhs in Delhi and other India cities was also associated with this movement.
2. CONTENTS
• Introduction
• Mechanism of action of antisense oligonucleotides
• Classes of oligonucleotides
• First generation Antisense oligonucleotides
• Second generation Antisense oligonucleotides
• Third generation Antisense oligonucleotides
• Applications
• Limitations
2
3. INTRODUCTION
• Antisense Oligonucleotides are unmodified or
chemically modified ssDNA, RNA or their analogs.
• They are 13-25 nucleotides long and are specifically
designed to hybridize to the corresponding mRNA by
Watson-Crick binding.
• In this technique short segments of single stranded
DNA called Oligodeoxynucleotides are introduced
in to the cell.
3
5. • The antisense effect of oligonucleotide sequence
waw first demonstrated in 1970s by Zamecnik and
Stephenson, in Rous sarcoma virus.
• When these oligonucleotides combined with target
mRNA, a DNA/RNA hybrid is formed, which is
degraded by enzyme Rnase H.
• RNaseH is a non specific endonuclease, catalyzed the
cleavage RNA via hydrolytic mechanism.
• It cleaves 3’-O-P bond of RNA in DNA/RNA duplex.
5
6. MECHANISM OF ACTION OF ANTISENSE
OLIGONUCLEOTIDES
• In this technique, short segments ssRNA
are introduced.
• These oligonucleotides are complement
-ary to mRNA, which bind to mRNA.
• So, they block the expression of particul
-ar gene.
• In case of viruses, antisense oligonucleotides
inhibit viral replication with blocking
expression of integrated proviral genes. 6
7. • Despite the simplicity of the idea behind Antisense
oligonucleotides, several problems have to be overcome for
successful application:
• Accessible sites of target RNA for oligonucleotide binding
have to be identified.
• Antisense agents have to protected against nuclease enzyme
attack.
• Cellular uptake and correct intracellular localization.
• It is therefore necessary to chemically modify antisense
oligonucleotides to make them stable in cells.
• Modification of phosphodiester backbone is likely to inhibit
nuclease action and several phosphodiester backbone
analogues have been developed with thios goal in mind.
7
8. CLASSES OF OLIGONUCLEOTIDES
• On the basis of mechanism of action, two classes of
antisense oligonucleotides can be identified:
• The Rnase-H-dependent oligonucleotides, which
induce the degradation of mRNA
• The steric-blocker oligonucleotides, which
physically prevent or inhibit progression of splicing or
translational machinery.
8
9. FIRST GENERATION ANTISENSE
OLIGONUCLEOTIDES
• First synthesised by Eckstein and collagues in 1960s.
• Phosphoro-thioate-deoxy-nucleotide are the first gen.
oligonucleotides and have sulfur atom replacing the
non bridging oxygen of sugar phosphate backbone. It
preserves the overall charge and can also activate
RNaseH for degradation of mRNA.
9
10. CHARECTERISTICS OF FIRST GEN.
• Better stability to nucleases but still degrades.
• Can activate Rnase H.
• Are highly soluble and have excellent antisense
activity.
• They were first used as antisense oligonucleotides for
inhibition og HIV.
• Cannot cross lipid bilayer because of their charge and
polarity.
10
11. SIDE EFFECTS
• Thrombocytopenia
• Fever
• Fatigue
• Rashes
• Luekopenia
• There is also transient inhibition of clotting times
shown by an increased activated partial
thromboplastin time(aPTT)
11
12. SECOND GENERATION ANTISENSE
OLIGONUCLEOTIDES
• Second generation Antisense oligonucleotides
containing nucleotides with alkyl modifications at 2’
position of ribose
• 2’-O-methyl and 2’-O-methoxy-ethyl RNA are most
important member of this class.
12
13. 13
• These second gen. oligonucleotides are resistant to
degradation by cellular nucleases and hybridize
specifically to their target mRNA with higher affinity
than phosphodiester or phosphorothioate.
• However such antisense effects result from Rnase H
independent mechanisms.
14. CHARECTERISTICS OF SECOND GEN.
• Mechanism of action for 2’ modified oligonucleotides
do not rely on Rnase H activation but on translation
arrest by blocking 80s ribosome complex formation
as well as with splicing interference.
• They were developed to try and avoid toxicity
associated with first generation AS-ONs.
• Show high binding affinity to target mRNA.
• Best stability to nucleases.
• Less toxic than first gen. AS-ONs.
• Higher lipophilicity compared to first gen.
14
15. THIRD GENERATION ANTISENSE
OLIGONUCLEOTIDES
• Newest and most promising.
• Enhanced binding affinity and biostability.
• Peptide nucleic acids(PNAs)
• Locked nucleic acids(LNA)
• Tricyclo-DNA
• Cyclohexene nucleic acids(CeNA)
15
16. PEPTIDE NUCLEIC ACIDS(PNA)
• In PNAs the deoxyribose phosphate backbone is
replaced by polyamide linkages.
• The property of high affinity nucleic acid binding
can be explained by lack of electrostatic repulsion
because of absence of negative charges on PNA
oligomers.
• The antisense mechanism of PNAs depends on
steric hindrance.
16
17. LOCKED NUCLEIC ACIDS(LNA)
• The ribose ring is connected by methylene
bridge between 2’-O and 4’-C atoms thus
“locking the ribose ring”
• Thus pairing with complementary
nucleotide strand is more rapid and
increases stability of resulting duplex.
• LNA oligonucleotides exhibit
unprecedented thermal stability when
hybridized to a complementary DNA/RNA
strand.
17
18. CYCLOHEXENE NUCLEIC ACIDS(CENA)
• The replacement of furanose moiety of DNA by a
cyclohe.xene ring gives Cyclohexene nucleic acids.
• CeNA is stable against degradation in serum and a
CeNA/RNA hybrid is able to activate Rnase H,
resulting in cleavage of RNA strand.
18
19. 19
• These chemical modifications change the properties of
natural oligonucleotides in following way:
• Increase RNA affinity.
• Increased hydrophobicity.
• Increased stability towards nucleolytic degradation
• Inability to elicit Rnase H activity.
20. APPLICATIONS
• Antisense oligonucleotide therapy
• Oncology
• CNS and CVS therapeutics
• As antiviral and antibacterial agent e.g. Fomivirsen
• Inflammation therapeutics
• Diabetes
• Amyotrophic lateral sclerosis(ALS)
• Asthma
• Arthritis
• Duchene muscular dystrophy
20
21. LIMITATIONS
• Large doses are required for therapeutic response
• The difficulty in directing to particular cells
• Half life in plasma is short
21
22. OLIGONUCLEOTIDE DRUGS APPROVED
BY US-FDA
• Fomivirsen (1998)- marketed as Vitravene for
treatment of cytomegalovirus retinitis.
• Mipomersen (2013)- marketed as Kynamro for
treastment of homozygous familial
hypercholesterolemia.
• Eleplinsen (2016)- marketed as ExondlysSI for
Duchene Muscular Dystrophy.
• Nolersen (2018)- marketed as Tegsedi for
Amyloidosis and Polynueropathy.
• Casimersen (2021)- marketed as Amondys 45 for
Duchenne Muscular Dystrophy.
22
23. REFERENCES
• Genetic Engineering by Smita Rastogi and Neelam
Pathak.
• Antisense Oligonucleotides Technology in drug
discovery(DOI: 10.1517/17460441.1.4.285)
• Antisense Drug Technology Principlea stragies and
Applications by Stanley , T.Crooke
• https://www.slideshare.net/ Antisense drugs and
Oligonucleotides by Dr. Mohit Kulmi
23